Evaluation of the laser therapy clinical efficacy in chronic vulval dystrophic diseases

Abstract

It has been found that copper vapour laser emission is a highly effective treatment of chronic degenerative diseases of the vulva (HDZV): squamous cell hyperplasia and sclerotic depriving vulva (SLV). Application of a copper vapor laser can reduce the clinical manifestations of these diseases and decrease the frequency of recurrences. The basis of pathogenesis-based treatment is normalization of hormonal status in patients with vulvar squamous cell hyperplasia (PRTs) and immunomodulatory effects, manifested by normalization of major subpopulations of immunocompetent cells relations, changes in the level of expression of receptors for interleukin-2 and transferrin on lymphocytes, increased levels of nonspecific resistance.

Keywords

squamous hyperplasia of vulva / sclerotic lichen of the vulva / laser therapy / adrenocortical hormones / immune status

References

[1] Зайнуллина Р.М. Комплексное лечение дистрофических заболеваний наружных гениталий: Дисс. Уфа, 1995.

[2] Штемберг М.И., Шендерова Т.С. Комплексная патогенетическая терапия крауроза и лейкоплакии вульвы. Здравоохранение (Кишинев). 1980; 4: 10.

[3] Ayhan A., Yuce K., Urman B. et al. Vulvar dystrophies: an evaluation. Aust. N. Z. J. Obstet. Gynaecol. 1989; 29(3): 250-2.

[4] Воробьева Л.И., Тарутинов В.И., Моевская Л.П. Нарушение гормонального гомеостаза у больных краурозом, лейкоплакией и раком вульвы. Экспериментальная онкология. 1992; 14(5): 78-80.

[5] Bogatyrev V.N., Grigoruk O.G., Lazarev A.F., Bazulina L.M. Potentialities of cytological method in diagnostics of HPV - infection of cervix uteri based on cytological screening. 34th European congress of Cytology, 15-18 june 2008, Rovaniemi, Finland. Cytopathology. 2008; 19 (Suppl. 1) 91.

[6] Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther. 2004; 17(1): 28-37.

[7] Goldstein A.T., Marinoff S.C., Christopher K., Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J. Reprod. Med. 2005; 50(7): 477-80.

[8] Abramov Y, Elchalal U., Abramov D. Surgical treatment of vulvar lichen sclerosus: a review. Obstet.Gynecol. Surv. 1996; 51(3): 193-9.

[9] Ambros R.A., Malfetano J.H., Carlson J.A. et al. Non-neoplastic epithelial alterations of the vulva: recognition assessment and comparisons of terminologies used among the various specialties. Mod. Pathol. 1997; 10(5): 401-8.

[10] Bracco G.L., Carli P., Sonni L. et al. Clinical and histological effects of topical treatments of vulval lichen sclerosus. A critical evaluation. J. Reprod. Med. 1993; 38(1): 37-40.

[11] Scrimin F., Rustja S., Radillo O. et al. Vulvar lichen sclerosus: an immunologic study. Obstet and Gynecol. 2000; 95(1): 147-150.

[12] Carlson J.A., Grabowski R., Chichester P. et al. Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous-implications for pathogenesis. Am J. Dermatopathol. 2000; 22(1): 7-16.

[13] Foldes-Papp Z., Reich O., Demel U., Tilz G.P. Lack of specific immunological disease pattern in vulvar lichen sclerosus. Exp. Mol. Pathol. 2005; 79(2): 176-85.

[14] Борисова А.М., Хорошилова Н.В., Булгакова Г.И. Действие низкоинтенсивного лазерного излучения на иммунную систему. Терапевтический архив. 1992; 5: 111-6.

[15] Kaufman R.H., Friedrich E.G. The carbon dioxide laser in the treatment of vulvar disease. Clin. Obstet. Gynecol. 1985; 28(1) 220-9.

[16] Val I., Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol. 2005; 48(4): 808-17.

[17] Harrington C.I., Dunsmore I.R. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus. Br. J. Dermatol. 1981; 104(5): 563-6.

RIGHTS & PERMISSIONS

Eco-Vector